UBS Group
PBH icon

UBS Group’s Prestige Consumer Healthcare PBH Stock Holding History

UBS Group’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,000
Closed -$56K – 7893
2017
Q1 		$56K Hold
1,000
– – ﹤0.01% 5438
2016
Q4 		$52K Sell
1,000
-1,000
-50% -$48.3K ﹤0.01% 5800
2016
Q3 		$97K Buy
+2,000
New +$101K ﹤0.01% 5013

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group's PBH Position: Q1 2026 in Review

UBS Group reduced its Prestige Consumer Healthcare (PBH) stake by 7.5% in Q1 2026, selling an estimated $2.08M and leaving 392,209 shares worth $23.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

UBS Group first reported a position in PBH in Q4 2014 and has held it in 46 quarters since. The position peaked at $30.6M in Q2 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • UBS Group held 392,209 shares of Prestige Consumer Healthcare worth $23.2M as of Q1 2026.
  • UBS Group sold 32,021 Prestige Consumer Healthcare shares in Q1 2026, an estimated $2.08M.
  • Prestige Consumer Healthcare made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2420 holding.
  • UBS Group first reported a position in Prestige Consumer Healthcare in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Prestige Consumer Healthcare position peaked at $30.6M in Q2 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.